| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-133 |
Sentence |
denotes |
Cloning of a human UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase catalyzing the formation of type 1 chains. |
| T1 |
0-133 |
Sentence |
denotes |
Cloning of a human UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase catalyzing the formation of type 1 chains. |
| T2 |
134-346 |
Sentence |
denotes |
Biochemical evidence suggests that the galactosyltransferase activity synthesizing type 1 carbohydrate chains is separate from the well characterized enzyme that is responsible for the synthesis of type 2 chains. |
| T2 |
134-346 |
Sentence |
denotes |
Biochemical evidence suggests that the galactosyltransferase activity synthesizing type 1 carbohydrate chains is separate from the well characterized enzyme that is responsible for the synthesis of type 2 chains. |
| T3 |
347-532 |
Sentence |
denotes |
This was recently confirmed by the cloning, from melanoma cells, of an enzyme capable of synthesizing type 1 chains, which was shown to have no homology to other galactosyltransferases. |
| T3 |
347-532 |
Sentence |
denotes |
This was recently confirmed by the cloning, from melanoma cells, of an enzyme capable of synthesizing type 1 chains, which was shown to have no homology to other galactosyltransferases. |
| T4 |
533-676 |
Sentence |
denotes |
We report here the molecular cloning and functional expression of a second human beta3-galactosyltransferase distinct from the melanoma enzyme. |
| T4 |
533-676 |
Sentence |
denotes |
We report here the molecular cloning and functional expression of a second human beta3-galactosyltransferase distinct from the melanoma enzyme. |
| T5 |
677-861 |
Sentence |
denotes |
The new beta3-galactosyltransferase has homology to the melanoma enzyme in the putative catalytic domain, but has longer cytoplasmic and stem regions and a carboxyl-terminal extension. |
| T5 |
677-861 |
Sentence |
denotes |
The new beta3-galactosyltransferase has homology to the melanoma enzyme in the putative catalytic domain, but has longer cytoplasmic and stem regions and a carboxyl-terminal extension. |
| T6 |
862-942 |
Sentence |
denotes |
Northern blots showed that the new gene is present primarily in brain and heart. |
| T6 |
862-942 |
Sentence |
denotes |
Northern blots showed that the new gene is present primarily in brain and heart. |
| T7 |
943-1097 |
Sentence |
denotes |
When transfected into mammalian cells, this gene directs the synthesis of type 1 chains as determined by a monoclonal antibody specific for sialyl Lewisa. |
| T7 |
943-1097 |
Sentence |
denotes |
When transfected into mammalian cells, this gene directs the synthesis of type 1 chains as determined by a monoclonal antibody specific for sialyl Lewisa. |
| T8 |
1098-1180 |
Sentence |
denotes |
A soluble version of the cloned enzyme was expressed in insect cells and purified. |
| T8 |
1098-1180 |
Sentence |
denotes |
A soluble version of the cloned enzyme was expressed in insect cells and purified. |
| T9 |
1181-1281 |
Sentence |
denotes |
The soluble enzyme readily catalyzes the transfer of galactose to GlcNAc to form Gal(beta1-3)GlcNAc. |
| T9 |
1181-1281 |
Sentence |
denotes |
The soluble enzyme readily catalyzes the transfer of galactose to GlcNAc to form Gal(beta1-3)GlcNAc. |
| T10 |
1282-1396 |
Sentence |
denotes |
It also has a minor but distinct transfer activity toward Gal, LacNAc, and lactose, but is inactive toward GalNAc. |
| T10 |
1282-1396 |
Sentence |
denotes |
It also has a minor but distinct transfer activity toward Gal, LacNAc, and lactose, but is inactive toward GalNAc. |